Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 19.90%-24.15M | ---- | 9.77%-30.14M | ---- | -3,081.52%-33.41M | ---- | 95.02%-1.05M | ---- | -400.57%-21.08M | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 78.09%-802K | ---- | 34.89%-3.66M | ---- | -62.61%-5.62M | ---- | -128.10%-3.46M | ---- | -21.09%-1.52M | ---- |
| Impairment and provisions: | 22.60%14.19M | ---- | 306.75%11.58M | ---- | --2.85M | ---- | ---- | ---- | --16.48M | ---- |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --16.48M | ---- |
| -Impairment of trade receivables (reversal) | 21.02%2.49M | ---- | --2.06M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | 22.94%11.71M | ---- | 234.54%9.52M | ---- | --2.85M | ---- | ---- | ---- | ---- | ---- |
| Revaluation surplus: | ---- | ---- | -324.30%-3.54M | ---- | 1,794.62%1.58M | ---- | ---93K | ---- | ---- | ---- |
| -Other fair value changes | ---- | ---- | -324.30%-3.54M | ---- | 1,794.62%1.58M | ---- | ---93K | ---- | ---- | ---- |
| Asset sale loss (gain): | 25.35%2.13M | ---- | 450.52%1.7M | ---- | -8,183.33%-485K | ---- | -87.23%6K | ---- | 176.47%47K | ---- |
| -Loss (gain) from sale of subsidiary company | 23.00%2.08M | ---- | --1.69M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | 330.77%56K | ---- | 102.68%13K | ---- | -8,183.33%-485K | ---- | -87.23%6K | ---- | 176.47%47K | ---- |
| Depreciation and amortization: | -19.09%7.12M | ---- | 59.52%8.8M | ---- | 13.66%5.52M | ---- | -58.06%4.85M | ---- | -43.47%11.57M | ---- |
| -Amortization of intangible assets | 126.67%374K | ---- | 511.11%165K | ---- | --27K | ---- | ---- | ---- | ---- | ---- |
| Financial expense | -84.97%597K | ---- | 275.69%3.97M | ---- | 147.54%1.06M | ---- | -78.25%427K | ---- | -42.90%1.96M | ---- |
| Unrealized exchange loss (gain) | ---- | ---- | -21.02%-3.43M | ---- | -1,218.97%-2.83M | ---- | -26.02%253K | ---- | -72.75%342K | ---- |
| Special items | ---- | ---- | ---680K | ---- | ---- | ---- | 99.48%-12K | ---- | -142.00%-2.29M | ---- |
| Operating profit before the change of operating capital | 94.10%-908K | ---- | 50.88%-15.4M | ---- | -3,485.53%-31.35M | ---- | -83.20%926K | ---- | -84.86%5.51M | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---2.34M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Accounts receivable (increase)decrease | 88.39%-2.82M | ---- | -4,631.72%-24.29M | ---- | -96.98%536K | ---- | 214.34%17.73M | ---- | -37.99%-15.51M | ---- |
| Accounts payable increase (decrease) | -208.44%-12.3M | ---- | 524.63%11.34M | ---- | 82.42%-2.67M | ---- | -191.32%-15.19M | ---- | 535.09%16.64M | ---- |
| Special items for working capital changes | 1,740.22%1.51M | ---- | ---92K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from business operations | 40.74%-16.85M | ---- | 15.07%-28.44M | ---- | -1,067.49%-33.49M | ---- | -47.92%3.46M | ---- | -68.85%6.65M | ---- |
| Other taxs | 57.37%-191K | ---- | -34.53%-448K | ---- | -350.00%-333K | ---- | 60.64%-74K | ---- | 95.94%-188K | ---- |
| Special items of business | ---- | 179.18%20.35M | ---- | -287.95%-25.69M | ---- | -1,237.97%-6.62M | ---- | -88.74%582K | ---- | -63.82%5.17M |
| Net cash from operations | 41.00%-17.04M | 179.18%20.35M | 14.58%-28.89M | -287.95%-25.69M | -1,098.46%-33.82M | -1,237.97%-6.62M | -47.55%3.39M | -88.74%582K | -61.35%6.46M | -63.82%5.17M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -85.54%362K | ---- | -63.69%2.5M | ---- | 151.77%6.9M | ---- | 259.45%2.74M | ---- | -31.60%762K | ---- |
| Loan receivable (increase) decrease | -94.42%1.05M | ---- | 65.56%18.88M | ---- | 119.93%11.41M | ---- | ---57.22M | ---- | ---- | ---- |
| Decrease in deposits (increase) | 150.00%5M | ---- | ---10M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Sale of fixed assets | ---- | ---- | -91.98%139K | ---- | --1.73M | ---- | ---- | ---- | ---- | ---- |
| Purchase of fixed assets | -70.86%-2.19M | ---- | -134.86%-1.28M | ---- | 81.52%-545K | ---- | -879.73%-2.95M | ---- | 92.05%-301K | ---- |
| Purchase of intangible assets | ---- | ---- | ---10.35M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Sale of subsidiaries | 666.72%6.9M | ---- | ---1.22M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---558K | ---- | ---- | ---- | --1.43M | ---- | ---- | ---- | ---- | ---- |
| Recovery of cash from investments | ---- | ---- | ---- | ---- | ---- | ---- | --40M | ---- | ---- | ---- |
| Cash on investment | ---- | ---- | ---- | ---- | ---- | ---- | -14.97%-6.9M | ---- | ---6M | ---- |
| Other items in the investment business | ---586K | -102.61%-664K | ---- | 191.26%25.45M | --6.9M | 942.72%8.74M | ---- | 106.91%838K | ---- | 113.33%405K |
| Net cash from investment operations | 856.21%9.98M | -102.61%-664K | -104.75%-1.32M | 191.26%25.45M | 214.32%27.81M | 942.72%8.74M | -339.23%-24.33M | 106.91%838K | -107.14%-5.54M | 113.33%405K |
| Net cash before financing | 76.62%-7.06M | 8,165.98%19.68M | -403.10%-30.21M | -111.54%-244K | 71.33%-6M | 48.94%2.12M | -2,381.26%-20.94M | -74.52%1.42M | -93.46%918K | -50.44%5.57M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | ---- | 40.17%6.42M | ---- | --4.58M | ---- | ---- | ---- | ---- | ---- |
| Refund | 63.50%-3.01M | ---- | -221.29%-8.24M | ---- | ---2.56M | ---- | ---- | ---- | ---10M | ---- |
| Issuing shares | 262.75%59.76M | ---- | -48.49%16.47M | ---- | 156.38%31.98M | ---- | -9.12%12.47M | ---- | --13.73M | ---- |
| Interest paid - financing | 84.97%-597K | ---- | -275.69%-3.97M | ---- | -147.54%-1.06M | ---- | 78.25%-427K | ---- | 42.90%-1.96M | ---- |
| Other items of the financing business | ---- | 732.36%53.66M | ---613K | 426.93%6.45M | ---- | 24.12%-1.97M | ---- | 70.44%-2.6M | ---- | 7.79%-8.79M |
| Net cash from financing operations | 5,611.76%46.61M | 732.36%53.66M | -97.19%816K | 426.93%6.45M | 239.15%29.04M | 24.12%-1.97M | 214.37%8.56M | 70.44%-2.6M | 20.62%-7.49M | 7.79%-8.79M |
| Effect of rate | 34.13%1.46M | 141.73%598K | 300.92%1.09M | -409.96%-1.43M | -113.83%-541K | -1,024.00%-281K | -8.12%-253K | 58.33%-25K | 77.78%-234K | -2,100.00%-60K |
| Net Cash | 234.56%39.55M | 1,082.38%73.34M | -227.58%-29.39M | 4,237.76%6.2M | 286.10%23.04M | 112.13%143K | -88.45%-12.38M | 63.37%-1.18M | -242.84%-6.57M | -288.03%-3.22M |
| Begining period cash | -36.27%49.72M | -36.27%49.72M | 40.51%78.03M | 40.51%78.03M | -18.53%55.53M | -18.53%55.53M | -9.07%68.16M | -9.07%68.16M | 4.97%74.97M | 4.97%74.97M |
| Cash at the end | 82.46%90.73M | 49.36%123.66M | -36.27%49.72M | 49.47%82.8M | 40.51%78.03M | -17.27%55.39M | -18.53%55.53M | -6.60%66.96M | -9.07%68.16M | -1.98%71.69M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | Deloitte Touche Tohmatsu Limited | -- | Deloitte Touche Tohmatsu Limited | -- | Deloitte Touche Tohmatsu Limited | -- | Jindao Liancheng Certified Public Accountants Co., Ltd. | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.